(Q44572628)

4 December 2017

Regulation of MMP-9 (gelatinase B) in activated human monocyte/macrophages by two different types of bisphosphonates (English)

1 reference

4 December 2017

Valleala H

1

1 reference

4 December 2017

Hanemaaijer R

2

1 reference

4 December 2017

Mandelin J

3

1 reference

4 December 2017

Salminen A

4

1 reference

4 December 2017

Teronen O

5

1 reference

4 December 2017

Mönkkönen J

6

1 reference

4 December 2017

Konttinen YT

7

1 reference

4 December 2017

language of work or name

English

0 references

publication date

1 September 2003

1 reference

4 December 2017

1 reference

4 December 2017

73

1 reference

4 December 2017

19

1 reference

4 December 2017

2413-2420

1 reference

Bisphosphonates and the prevention of metastasis: first evidences from preclinical and clinical studies

4 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900657-X

Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900657-X

A novel and simple immunocapture assay for determination of gelatinase-B (MMP-9) activities in biological fluids: saliva from patients with Sjögren's syndrome contain increased latent and active gelatinase-B levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900657-X

Changes associated with aging and replicative senescence in the regulation of transcription factor nuclear factor-kappa B.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900657-X

Matrix metalloproteinases: biologic activity and clinical implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900657-X

Randomized, placebo-controlled trial of clodronate in patients with primary operable breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900657-X

Bisphosphonate action. Alendronate localization in rat bone and effects on osteoclast ultrastructure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900657-X

Inhibition of matrix metalloproteinase-1 by dichloromethylene bisphosphonate (clodronate).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900657-X

MMP inhibition and downregulation by bisphosphonates.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900657-X

Critical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900657-X

Alendronate stimulates collagenase 3 expression in osteoblasts by posttranscriptional mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900657-X

Lipopolysaccharide induces expression of genes encoding pro-inflammatory cytokines and the elastin-degrading enzyme, cathepsin S, in human cervical smooth-muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900657-X

10.1016/S0024-3205(03)00657-X

7 January 2021

Identifiers

DOI

1 reference

4 December 2017

1 reference